Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sixavit CVN
- Development stage
- Unknown
- Lead developer
- Caplet India
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Sixavit CVN is a multivitamin, multimineral, and antioxidant dietary supplement developed by Caplet India. It is formulated as a combination of alpha lipoic acid, benfotiamine, beta carotene, biotin, calcium carbonate, chromium polynicotinate, folic acid, inositol, methylcobalamin, selenium, vitamin B6, and vitamin D3. The supplement is primarily used to support nerve health, manage diabetic neuropathy, and address nutritional deficiencies. The combination of alpha lipoic acid, benfotiamine, and methylcobalamin helps protect and regenerate nerve tissues, reducing symptoms like tingling, numbness, and pain associated with diabetic neuropathy, while other vitamins and minerals support energy production, antioxidant defense, and overall physiological function.
- Brand names
- Sixavit CVN
- Other names
- Sixavit CVN TabletSixavit-Cvn Softgel Capsulealpha lipoic acid + benfotiamine + beta carotene + biotin + calcium carbonate + chromium polynicotinate + folic acid + inositol + methylcobalamin + selenium + vitamin B6 + vitamin D3alpha lipoic acid + benfotiamine + beta carotene + biotin + chromium polynicotinate + folic acid + inositol + methylcobalamin + selenium + vitamin B6alpha lipoic acid + benfotiamine + calcium carbonate + chromium polynicotinate + folic acid + inositol + methylcobalamin + pyridoxine + vitamin D3
02
Targets
GPX4 (Glutathione peroxidase 4)MTR (Methionine synthase)
Beyond the preview
Go deeper on Sixavit CVN.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sixavit CVN.